Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Autologous alpha-DC1/TBVA vaccine |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
Autologous alpha-DC1/TBVA vaccine is comprised of patient-derived dendritic cells loaded with tumor blood vessel antigen (TBVA)-derived peptides, which may lead to increased antitumor immune response (PMID: 34782430). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Autologous alpha-DC1/TBVA vaccine | Autologous alpha-DC1/TBVA vaccine | 0 | 0 |
| Autologous alpha-DC1/TBVA vaccine + Cabozantinib | Autologous alpha-DC1/TBVA vaccine Cabozantinib | 0 | 1 |
| Autologous alpha-DC1/TBVA vaccine + Dasatinib | Autologous alpha-DC1/TBVA vaccine Dasatinib | 0 | 0 |